6550--Notice of Intent to Sole Source; Qiagen LLC
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Sep 1, 2026 |
| Due Date: | Sep 15, 2026 |
| Solicitation No: | 36C24226Q0960 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
Follow
Active
Contract Opportunity
Notice ID
36C24226Q0960
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
242-NETWORK CONTRACT OFFICE 02 (36C242)
General Information
Classification
Description
This is a notice of intent to award a sole source contract and is not a request for quotes.
The Department of Veterans Affairs (DVA) Network Contracting Office NCO2, on behalf of VISN2 South Medical Centers, intends to award a Firm Fixed Price (FFP), sole source action to:
Name of Contractor:
QIAGEN LLC
Street Address:
19300 Germantown Road
City, State, Zip:
Germantown, MD 20874-1415
VISN02 medical centers have a recurring requirement for US Food & Drug Administration (FDA) approved In Vitro Diagnostic (IVD), cell mediated immunity (IGRA) tests for detecting Mycobacterium infections using chemiluminescence immunoassay (CLIA) on LIAISON analyzers.
Market research was conducted in accordance with FAR Part 10, reviewing the offerings and capabilities available through the current marketplace. In accordance with the Revolutionary FAR Overhaul (RFO) Part 6.103-1, it has been determined that only one source is reasonably available, QIAGEN LLC.
QIAGEN is the manufacturer and sole distributor of the QuantiFERON TB Gold testing. QuantiFERON is the only test capable of meeting the salient characteristics of the requirement and providing the necessary compatibility with the Department of Veterans Affairs existing LIAISON analyzers.
Market research failed to produce additional sources capable of fulfilling this requirement as a whole; No subcontracting opportunities are available for this requirement.
In accordance with the Revolutionary FAR Overhaul (RFO) this notice of intent to sole source with justification to limit sources, satisfies the public posting requirements.
Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels.
This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on September 15, 2025. Responses to be submitted to Lindsay Goldsmith, Contracting Officer at lindsay.goldsmith@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Aug 31, 2026 10:43 pm EDT
- Original Response Date: Sep 15, 2026 10:00 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Sep 30, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
This is a notice of intent to award a sole source contract and is not a request for quotes.
The Department of Veterans Affairs (DVA) Network Contracting Office NCO2, on behalf of VISN2 South Medical Centers, intends to award a Firm Fixed Price (FFP), sole source action to:
Name of Contractor:
QIAGEN LLC
Street Address:
19300 Germantown Road
City, State, Zip:
Germantown, MD 20874-1415
VISN02 medical centers have a recurring requirement for US Food & Drug Administration (FDA) approved In Vitro Diagnostic (IVD), cell mediated immunity (IGRA) tests for detecting Mycobacterium infections using chemiluminescence immunoassay (CLIA) on LIAISON analyzers.
Market research was conducted in accordance with FAR Part 10, reviewing the offerings and capabilities available through the current marketplace. In accordance with the Revolutionary FAR Overhaul (RFO) Part 6.103-1, it has been determined that only one source is reasonably available, QIAGEN LLC.
QIAGEN is the manufacturer and sole distributor of the QuantiFERON TB Gold testing. QuantiFERON is the only test capable of meeting the salient characteristics of the requirement and providing the necessary compatibility with the Department of Veterans Affairs existing LIAISON analyzers.
Market research failed to produce additional sources capable of fulfilling this requirement as a whole; No subcontracting opportunities are available for this requirement.
In accordance with the Revolutionary FAR Overhaul (RFO) this notice of intent to sole source with justification to limit sources, satisfies the public posting requirements.
Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels.
This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on September 15, 2025. Responses to be submitted to Lindsay Goldsmith, Contracting Officer at lindsay.goldsmith@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
Attachments/Links
Contracting Office Address
- 113 HOLLAND AVE
- ALBANY , NY 12208
- USA
Primary Point of Contact
- Lindsay Goldsmith
- Lindsay.Goldsmith@va.gov
- Phone Number (518) 626-7194
Secondary Point of Contact
- Aug 31, 2026 10:43 pm EDTSpecial Notice (Original)
Get Government Bids Like This by Email
Receive daily bid alerts that match your keywords, business categories, and target regions.
See Also
Follow 6550--Lab - ABBOTT ARCHITECT REAGENTS AND CONSUMABLES Active Contract Opportunity Notice ID
VETERANS AFFAIRS, DEPARTMENT OF
Due by 11/12/2026
Follow Epinephrine Injector Active Contract Opportunity Notice ID SPE2D2-26-R-0009 Related Notice SPE2D2-26-R-0009 Department/Ind.
DEPT OF DEFENSE
Due by 11/16/2026
Bid Number Bid Title Bid Type Organization Bid Issue Date Bid Close Date
San Antonio Water System
Due by 11/10/2026
Follow DLA Medical Equipment Electronic CATalog (ECAT) Generation V Program Active Contract Opportunity
DEPT OF DEFENSE
Due by 12/01/2026
* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.